SCHEMBL484769

SCHEMBL484769

Cn1cccc1CN1CCC2(CC1)CCN(C(=O)c1ccc3c(c1)C(N(C(=O)c1ccccc1Cl)C1CC1)CC3)C2

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 9/20 0.36
CYP2C19 P33261 4/20 0.36
CYP3A4 P08684 5/20 0.35
CYP1A2 P05177 4/20 0.35
TSHR P16473 5/20 0.34
USP2 O75604 5/20 0.34
CYP2C9 P11712 3/20 0.34
HIF1A Q16665 1/20 0.34
EPHX2 P34913 1/20 0.34
HTR4 Q13639 1/20 0.33
CHRM2 P08172 2/20 0.33
CHRM3 P20309 2/20 0.33
MAPK1 P28482 1/20 0.33
AR P10275 1/20 0.32
PARP1 P09874 1/20 0.32
HSD11B1 P28845 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL484711 0.90 KCNH2 (0.38) CYP2D6CYP2C19CYP3A4CYP1A2TSHR
SCHEMBL484872 0.86 CYP2D6 (0.39) CYP2D6CYP2C19CYP3A4CYP1A2TSHR
SCHEMBL2820483 0.85 CYP2D6 (0.38) CYP2D6CYP2C19CYP3A4CYP1A2TSHR
SCHEMBL484434 0.85 CYP2D6 (0.39) CYP2D6CYP2C19CYP3A4CYP1A2TSHR
SCHEMBL484643 0.85 CYP3A4 (0.46) CYP2D6CYP2C19CYP3A4CYP1A2TSHR
SCHEMBL2816549 0.85 CYP2D6 (0.39) CYP2D6CYP2C19CYP3A4CYP1A2TSHR
SCHEMBL486049 0.84 HSD11B1 (0.39) EPHX2PARP1HSD11B1
SCHEMBL484397 0.84 CYP2D6 (0.39) CYP2D6CYP2C19CYP3A4CYP1A2TSHR
SCHEMBL485288 0.84 CYP2D6 (0.40) CYP2D6CYP2C19CYP3A4CYP1A2TSHR
SCHEMBL484682 0.84 CHRM2 (0.46) CYP2D6CYP2C19CYP3A4CYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN CYP2D6 1926/4885CYP2C19 2325/4885CYP3A4 3781/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN CYP2D6 1926/4885CYP2C19 2325/4885CYP3A4 3781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.